The Effectiveness of Electroacupuncture and Standard Therapy Compared to Standard Therapy in Gynecological Cancer Pain
1 other identifier
interventional
58
1 country
3
Brief Summary
Gynecological cancer is cancer that starts in the female reproductive organs. Pain in gynecological cancer can be caused by an underlying malignancy or surgical procedure as well as chronic pain associated with malignancy and sequelae of the therapy given. Gynecological cancer patients often experience moderate to severe pain and use higher levels of opioids than patients diagnosed with other cancers. More than two thirds of patients with advanced cancer experience severe pain and up to half of these patients report that their pain is not well controlled. This study aims to analyze the effectiveness of electroacupuncture plus standard therapy on pain intensity (VAS score), changes in analgesic dose, and quality of life (QLQ C-30 EORTC score) in patients with gynecological cancer pain compared to standard therapy alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2023
CompletedFirst Submitted
Initial submission to the registry
October 4, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2023
CompletedJanuary 29, 2024
January 1, 2024
4 months
October 4, 2023
January 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain severity with Visual Analog Scale
Rating scale for measuring pain, where the minimum value is 0 = no pain, and the maximum value is 100 = severe pain. A higher scale means worse outcomes.
Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
Secondary Outcomes (2)
European Organisation for Research and Treatment of Cancer Quality of Life C30
before treatment and 7 day after treatment
Analgetic Usage in dosage and frequency
Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
Study Arms (2)
Control
NO INTERVENTIONThe Patient are cancer patient that experience cancer pain that only receive analgetic drug treatment according to WHO Stepledder of Pain
Electroacupuncture and standard Therapy
EXPERIMENTALThe Patient are cancer patient that experience cancer paint that receive analgetic drug treatement according WHO stepledder of pain and receive electroacupuncture
Interventions
Patient receive analgetic medicine will get experimental procedure with needle insertion that attach to eletrostimulator
Eligibility Criteria
You may qualify if:
- Female 18 to 65 years old
- Gynecocal cancer with pain ≥ 4 acording Visual Analog scale and receive analgetic medicine
- The pain cause by
- direct from cancer
- Treatment proces surgery, radiotherapy, chemotherapy, paliatif treatment, supportive treatment
- Adverse reaction form treatment and intoxication
You may not qualify if:
- Emergency case patient with hemodynamic instable
- Patient with uncooperative behavior because ith serious psychological disorders, no currently undergoing psychiatric treatment, aggressive behavior, that not allowed for acupuncture.
- Patients with blood clotting disorders, with platelets \<50.000 and in neutropenic condition with \<1000 neutrophils.
- The patient has an allergy to stainless steel acupuncture needles. Wounds at the acupuncture point puncture sites, skin infections in the ears. On patients with eczema on the ears, external otitis or psoriasis.
- There is a tumor in the area that will be stabbed and stimulated in the stomach pregnant women, close to the heart, or in the area of the carotid sinus lymphedema, insertion into the prosthesis.
- Patients with heart rhythm disorders. The patient uses a pace maker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Fatmawati Hospital
Jakarta, DKI Jakarta, 12430, Indonesia
Persahabatan Hospital
Jakarta, DKI Jakarta, 13230, Indonesia
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, 10430, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
KEPK FKUI-RSCM
The Ethics Committee of the Faculty of Medicine, University of Indonesia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- asessor
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
October 4, 2023
First Posted
October 10, 2023
Study Start
August 30, 2023
Primary Completion
December 19, 2023
Study Completion
December 19, 2023
Last Updated
January 29, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share